- Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again Reuters
- Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance CNBC
- Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short Bloomberg.com
- Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO Yahoo Finance
- Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic MarketWatch
Source link